Primary Hyperoxaluria Type 1 clinical trials

Explore recruiting primary hyperoxaluria type 1 clinical trials.

Recruiting primary hyperoxaluria type 1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Hyperoxaluria Type 1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ILLUMINATE-C: A Single Arm Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1 (PH1)

France, Netherlands, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1/2 Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of ABO-101 in Participants with Primary Hyperoxaluria Type 1 (PH1)

Germany, France, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Evaluation of the efficacy and safety of stiripentol in patients 6 years and older with primary hyperoxaluria type 1, 2 or 3

France, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis

Germany, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary Hyperoxaluria Type 1 trials by city

Primary Hyperoxaluria Type 1 in Toronto Primary Hyperoxaluria Type 1 in Vancouver Primary Hyperoxaluria Type 1 in Montreal Primary Hyperoxaluria Type 1 in Calgary Primary Hyperoxaluria Type 1 in Edmonton Primary Hyperoxaluria Type 1 in Ottawa Primary Hyperoxaluria Type 1 in Winnipeg Primary Hyperoxaluria Type 1 in Quebec City Primary Hyperoxaluria Type 1 in Hamilton Primary Hyperoxaluria Type 1 in Kitchener Primary Hyperoxaluria Type 1 in London Primary Hyperoxaluria Type 1 in Halifax Primary Hyperoxaluria Type 1 in New York Primary Hyperoxaluria Type 1 in Los Angeles Primary Hyperoxaluria Type 1 in Chicago Primary Hyperoxaluria Type 1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease